CG Oncology, Inc. Financial Overview
CG Oncology, Inc.'s market cap is currently $3.01B. The company's EPS TTM is $-0.57; its P/E ratio is -19.15; CG Oncology, Inc. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
